See the DrugPatentWatch profile for menactra
What is Menactra used for?
Menactra is a vaccine that helps protect against invasive disease caused by certain types of meningococcal bacteria, specifically Neisseria meningitidis serogroups A, C, W, and Y. It is used to help prevent serious illnesses such as meningitis and bloodstream infections caused by those strains. [1]
What illness does it help prevent?
By targeting serogroups A, C, W, and Y, Menactra is intended to reduce the risk of meningococcal meningitis and related invasive meningococcal disease. [1]
Who typically gets Menactra?
The vaccine is used for people who are recommended to receive meningococcal vaccination, including children and adolescents in many immunization schedules, but the exact age and schedule depend on local guidance and the person’s vaccination history. [1]
What does “Menactra” contain?
Menactra is a meningococcal conjugate vaccine (a type that links the bacterial antigen to a carrier protein), designed to improve immune response to these serogroups. [1]
Are there side effects?
Like other vaccines, Menactra can cause side effects. Common ones may include reactions at the injection site and general symptoms such as fever or tiredness, though serious reactions are uncommon. [1]
How is Menactra different from other meningococcal vaccines?
Menactra is a meningococcal conjugate vaccine aimed at serogroups A, C, W, and Y. Other meningococcal vaccines may cover different serogroups (for example, some focus on serogroup B) or use different vaccine types. [1]
Sources
[1] https://www.fda.gov/vaccines-blood-biologics/meningococcal-vaccines/menactra-meningococcal-conjugate-vaccine-questions-and-answers